Written production and process control procedures are not documented at the time of performance.
Inspection Record
Kaysersberg Pharmaceuticals SAS — FDA 483 Findings
Inspectors Michael A CharlesThe inspectors who signed the published document.Inspector lookup
View the regulator's official source The source document is always the basis for judgement.
Findings
Laboratory controls do not include the establishment of scientifically sound and appropriate test procedures designed to assure that in-process materials conform to appropriate standards of identity, strength, quality and purity.
Written records of investigations into unexplained discrepancies do not always include the conclusions and follow-up.
Control procedures are not established which monitor the output and validate the performance of those manufacturing processes that may be responsible for causing variability in the characteristics of in- process material and the drug product.
Routine calibration of mechanical equipment is not performed according to a written program designed to assure proper performance.
Written procedures for cleaning and maintenance fail to include description in sufficient detail of methods, equipment and materials used and parameters relevant to the operation.
Aseptic processing areas are deficient regarding the system for monitoring environmental conditions.
There is a lack of written procedures describing in sufficient detail the methods, equipment and materials to be used for sanitation.
Similar findings at other companies
GRM selected findings from the same type of public document whose wording is close to a finding in this document. One per company.
- VitaCare Labs Inc.2025-05-16 · US FDASimilar to finding 3 Written records of investigations into unexplained discrepancies do not always include the conclusions and follow-up.
- LCC Ltd.2024-03-22 · US FDASimilar to finding 4 Control procedures are not established which monitor the output and validate the performance of those manufacturing processes that may be responsible for…
- GH Genhelix, S.A.2022-01-25 · US FDASimilar to finding 3 Written records of investigations into unexplained discrepancies do not always include conclusions and follow-up which are adequately justified.
- Frontage Laboratories, Inc.2026-04-14 · US FDASimilar to finding 2 Laboratory controls do not include the establishment of scientifically sound and appropriate test procedures designed to assure that drug products conform to…
- SURETEC INNOVATIONS LLC2026-03-05 · US FDASimilar to finding 2 Laboratory controls do not include the establishment of scientifically sound and appropriate test procedures designed to assure that drug products conform to…
A record as of the US FDA document published on 2026-10-23. Check the agency's announcements for any later corrective action, and rely on the original text. Translation and classification are machine-made.